Surgical treatment of hilar cholangiocarcinoma by hepatopancreatoduodenostomy

VernacularTitle:肝胰十二指肠切除术治疗肝门部胆管癌:附11例
Author: Kaiwang SHI ; Pengcheng XI ; Kunxing YANG ; Shaozhong NI
Publication Type:Journal Article
Keywords: Bile duct neoplasms; Hepatopancreatoduodenostomy
From: Chinese Journal of Hepatobiliary Surgery 2010;16(1):13-14
CountryChina
Language:Chinese
Abstract: Objective To summarize the experience in performance of hepatopancreatoduodenostomy for hilar cholangiocarcinoma. Methods The clinical data of 11 cases of hilar cholangiocarcinoma receiving hepatopancreatoduodenostomy in our hospital from June 2000 to January 2008 were retrospectively analyzed. Results For Bismush-corlitte classification, 8 cases were grade Ⅲ the others Ⅳ.Quadrate lobectomy plus pancreaticoduodenectomy was performed in 2 patients, caudate lobectomy plus pancreaticoduodenostomy in 5, hepatectomy in right half plus caudate lobectomy, pancreaticoduodenostomy and PV lateral wall partial resection and reconstruction in 1, hepatectomy in left half and pancreaticoduodenostomy in 3. There were no death. Three patients had the complication of biliary fistula,1 pancreatic fistula, 2 pulmonary infection and 1 liver functional failure. The follow-up in 8 patients showed that the longest survival was 63 months. Conclusion HPD is safe and feasible for treatment of hilar cholangiocarcinoma invading the region of pancreaticoduodensum and it can promote the life quality of patients.